FDA Regulatory Friday, July 10, 2026 +0.40 Positive

FDA Proposes Rule to Modernize Drug Manufacturing Registration

The FDA released a proposed rule to modernize drug manufacturing registration. The rule targets distributed manufacturing establishments utilizing a 'hub-and-spoke' model.

View original filing at SEC.gov →
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.

Get real-time financial news in your trading bot or app

GET FREE KEY — 10,000 calls/day